Andrew Peterson, MD, discusses the quality-of-life impact of post-cancer incontinence and advances in electronically controlled artificial urinary sphincters.
Related to this article
A recap of the FDA submissions and regulatory decisions in urology from August 2026.
Advertisement
Advertisement
Trending on Urology Times
1
Cameron Jones, MD, discusses patient selection for Aquablation
2
Andrew Peterson, MD, discusses advances in artificial urinary sphincter technology
3
Topical sildenafil cream associated with lower systemic exposure vs oral sildenafil
4
PSMA-targeted CD28 bispecific enters phase 1 trial in mCRPC
5